EUVIMEDEUVIMED entdecken
Crossref

Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients

Rahul D Barmanray iD, Mervyn Kyi iD, Leon J Worth iD, Peter G Colman iD, Leonid Churilov iD, Timothy N Fazio iD, Gerry Rayman iD, Vicky Gonzalez, Candice Hall, Spiros Fourlanos iD

The Journal of Clinical Endocrinology & Metabolism · 15.10.2024 · 109 (11) · e2048-e2056

DOI: 10.1210/clinem/dgae051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 27.01.2024. Verfasst von Rahul D Barmanray und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne 3000, Australia. Hauptthemen laut MEDLINE: Hyperglycemia, Acute Kidney Injury, Stroke, Hospitalization. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Rowe Family Foundation Perpetual Grant, Australian Government Research Training Program Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Hyperglycemia in hospital inpatients without pre-existing diabetes is associated with increased mortality. However, the independent contribution of hyperglycemia to health care–associated infection (HAI), acute kidney injury (AKI), and stroke is unclear.

Objective

To investigate the relationship between hyperglycemia and adverse clinical outcomes in hospital for patients with and without diabetes.

Methods

Diabetes IN-hospital: Glucose and Outcomes (DINGO) was a 26-week (October 2019-March 2020) prospective cohort study. Clinical and glucose data were collected up to the 14th day of admission. Primary stratification was by hyperglycemia, defined as ≥2 random capillary blood glucose (BG) measurements ≥11.1 mmol/L (≥200 mg/dL). Propensity weighting for 9 clinical characteristics was performed to allow interrogation of causality. To maintain the positivity assumption, patients with HbA1c >12.0% were excluded and prehospital treatment not adjusted for. The setting was the Royal Melbourne Hospital, a quaternary referral hospital in Melbourne, Australia. Admissions with at least 2 capillary glucose values and length of stay >24 hours were eligible, with half randomly sampled. Outcome measures were HAI, AKI, stroke, and mortality.

Results

Of 2558 included admissions, 1147 (45%) experienced hyperglycemia in hospital. Following propensity-weighting and adjustment, hyperglycemia in hospital was found to, independently of 9 covariables, contribute an increased risk of in-hospital HAI (130 [11.3%] vs 100 [7.1%], adjusted odds ratio [aOR] 1.03, 95% CI 1.01-1.05, P = .003), AKI (120 [10.5%] vs 59 [4.2%], aOR 1.07, 95% CI 1.05-1.09, P < .001), and stroke (10 [0.9%] vs 1 [0.1%], aOR 1.05, 95% CI 1.04-1.06, P < .001).

Conclusion

In hospital inpatients (HbA1c ≤12.0%), irrespective of diabetes status and prehospital glycemia, hyperglycemia increases the risk of in-hospital HAI, AKI, and stroke compared with those not experiencing hyperglycemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaAcute Kidney InjuryStrokeHospitalizationHumansMaleFemaleAgedMiddle AgedProspective StudiesBlood GlucoseCross InfectionInpatientsBiomarkersAged, 80 and overRisk FactorsHospital MortalityAustraliaPrognosis

Stichwörter der Autor:innen

acute kidney injurydiabetesglucometricshealth care–associated infectionhyperglycemiain-hospitaloutcomesstroke

Substanzen

Blood GlucoseBiomarkers

Autor:innen und Institutionen

  • Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne 3000, Australia.
  • Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Melbourne 3000, Australia.
  • Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, Melbourne 3000, Australia.
  • National Centre for Infections in Cancer (NCIC), Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne 3000, Australia.
  • Victorian Healthcare Associated Infection Surveillance System (VICNISS) Coordinating Centre, Doherty Institute, Melbourne 3000, Australia.
  • Health Intelligence Unit, The Royal Melbourne Hospital, Melbourne 3000, Australia.

ORCID-Profile: Rahul D Barmanray, Mervyn Kyi, Leon J Worth, Peter G Colman, Leonid Churilov, Timothy N Fazio, Gerry Rayman, Spiros Fourlanos

Förderung

  • Rowe Family Foundation Perpetual Grant
  • Australian Government Research Training Program Scholarship

Zitieren

APA

Barmanray, R. D., Kyi, M., Worth, L. J., Colman, P. G., Churilov, L., Fazio, T. N., Rayman, G., Gonzalez, V., Hall, C., & Fourlanos, S. (2024). Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients. The Journal of Clinical Endocrinology & Metabolism, 109(11), e2048-e2056. https://doi.org/10.1210/clinem/dgae051

Vancouver

Barmanray RD, Kyi M, Worth LJ, Colman PG, Churilov L, Fazio TN, et al. Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients. The Journal of Clinical Endocrinology & Metabolism. 2024;109(11):e2048-e2056. doi:10.1210/clinem/dgae051

BibTeX
@article{Barmanray2024,
  author = {Barmanray, Rahul D and Kyi, Mervyn and Worth, Leon J and Colman, Peter G and Churilov, Leonid and Fazio, Timothy N and Rayman, Gerry and Gonzalez, Vicky and Hall, Candice and Fourlanos, Spiros},
  title = {Hyperglycemia in Hospital: An Independent Marker of Infection, Acute Kidney Injury, and Stroke for Hospital Inpatients},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {11},
  pages = {e2048--e2056},
  doi = {10.1210/clinem/dgae051}
}
Kostenlos starten →